Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Lucentis on Psychological Morbidity in Patients With Macular Edema and Neovascularization Secondary to Retinal Vein Occlusion

NCT01011374 is registered in ClinicalTrials.gov with Retina Associates of Cleveland, Inc as lead sponsor.

NCT NCT01011374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01011374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Lucentis on Psychological Morbidity in Patients With Macular Edema and Neovascularization Secondary to Retinal Vein Occlusion
Lead sponsor
Retina Associates of Cleveland, Inc
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2009
Completion date
November 30, 2013
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion, depression, retinal vein occlusion, venous retinal branch occlusion